NIH study: Ebola vaccine safe in first 20 people studied, triggers promising immune response
November 26, 2014 at 16:34 PM EST
An experimental Ebola vaccine appears safe and triggered signs of immune protection in the first 20 volunteers to test it, U.S. researchers reported Wednesday.
